z-logo
open-access-imgOpen Access
Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Various Orbital Malignancies
Author(s) -
Aravintho Natarajan,
Piyush Chandra,
Nilendu Purandare,
Archi Agrawal,
Sneha Shah,
Ameya Puranik,
Venkatesh Rangarajan
Publication year - 2018
Publication title -
indian journal of nuclear medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.261
H-Index - 13
eISSN - 0972-3919
pISSN - 0974-0244
DOI - 10.4103/ijnm.ijnm_135_17
Subject(s) - medicine , positron emission tomography , computed tomography , fluorodeoxyglucose , radiology , positron emission , nuclear medicine , lesion , tomography , positron emission tomography computed tomography , pathology
Orbital swelling comprises wide spectrum of pseudotumors, benign and malignant tumor. Malignant tumor may be primary or secondary tumor, and they constitute about 36% of orbital tumors in adult. Fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) scan is extensively used in hematological malignancies and in solid tumors for staging, treatment response, and restaging. Recently, the use of FDG-PET/CT in orbital malignancies has gained importance. The aim of this pictorial essay is to illustrate few important orbital malignancies detected in F-18 FDG-PET/CT and discuss its role in assessing the primary lesion and associated systemic finding.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here